These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 12838495)

  • 1. Mycophenolate mofetil and cyclosporine therapy in membranous nephropathy.
    Cattran DC
    Semin Nephrol; 2003 May; 23(3):272-7. PubMed ID: 12838495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological Features of Idiopathic Membranous Nephropathy in 33 Adolescents.
    Li C; Li H; Wen YB; Li JN; Lin WF; Cai JF; Duan L; Li Y; Li XM; Li XW
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Aug; 39(4):544-551. PubMed ID: 28877834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Mycophenolate Mofetil versus Cyclosporine as Combination Therapy with Low Dose Corticosteroids in High-risk Patients with Idiopathic Membranous Nephropathy: a Multicenter Randomized Trial.
    Choi JY; Kim DK; Kim YW; Yoo TH; Lee JP; Chung HC; Cho KH; An WS; Lee DH; Jung HY; Cho JH; Kim CD; Kim YL; Park SH
    J Korean Med Sci; 2018 Feb; 33(9):e74. PubMed ID: 29441742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idiopathic membranous nephropathy in pediatric patients: presentation, response to therapy, and long-term outcome.
    Chen A; Frank R; Vento S; Crosby V; Chandra M; Gauthier B; Valderrama E; Trachtman H
    BMC Nephrol; 2007 Aug; 8():11. PubMed ID: 17683621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of current and alternative therapies for idiopathic membranous nephropathy.
    Tran TH; J Hughes G; Greenfeld C; Pham JT
    Pharmacotherapy; 2015 Apr; 35(4):396-411. PubMed ID: 25884528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multitarget therapy with a corticosteroid, cyclosporine and mycophenolate mofetil for idiopathic membranous nephropathy: a prospective randomized controlled trial.
    Duan Y; Bai Y; Guo W; Wang L; Dai W; Guo W; Huang H; Liu W; Diao Z
    Nephrol Dial Transplant; 2023 Dec; 39(1):95-102. PubMed ID: 37437905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolate mofetil therapy in children with idiopathic membranous nephropathy.
    Bhimma R; Naicker E; Ramdial PK
    Clin Nephrol; 2013 Dec; 80(6):441-8. PubMed ID: 24262490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of different therapies in high-risk patients with idiopathic membranous nephropathy.
    Peng L; Wei SY; Li LT; He YX; Li B
    J Formos Med Assoc; 2016 Jan; 115(1):11-8. PubMed ID: 26315481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
    Kwinta-Rybicka J; Wilkosz K; Wierzchowska-Słowiacze EK; Ogarek I; Moczulska A; Stec Z; Pełkowska A; Sancewicz-Pach K; Pietrzyk JA
    Przegl Lek; 2006; 63 Suppl 3():44-8. PubMed ID: 16898486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of mycophenolate mofetil in resistant membranous nephropathy.
    Miller G; Zimmerman R; Radhakrishnan J; Appel G
    Am J Kidney Dis; 2000 Aug; 36(2):250-6. PubMed ID: 10922302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycophenolate mofetil in idiopathic membranous nephropathy: a clinical trial with comparison to a historic control group treated with cyclophosphamide.
    Branten AJ; du Buf-Vereijken PW; Vervloet M; Wetzels JF
    Am J Kidney Dis; 2007 Aug; 50(2):248-56. PubMed ID: 17660026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive treatment for nephrotic idiopathic membranous nephropathy: a meta-analysis based on Chinese adults.
    Xie G; Xu J; Ye C; Chen D; Xu C; Yang L; Ma Y; Hu X; Li L; Sun L; Zhao X; Mao Z; Mei C
    PLoS One; 2012; 7(9):e44330. PubMed ID: 22957065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of idiopathic membranous nephropathy using targeted stepwise immunosuppressive treatment strategy.
    Aaltonen S; Honkanen E
    Nephrol Dial Transplant; 2011 Sep; 26(9):2871-7. PubMed ID: 21427071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycophenolate mofetil monotherapy in membranous nephropathy: a 1-year randomized controlled trial.
    Dussol B; Morange S; Burtey S; Indreies M; Cassuto E; Mourad G; Villar E; Pouteil-Noble C; Karaaslan H; Sichez H; Lasseur C; Delmas Y; Nogier MB; Fathallah M; Loundou A; Mayor V; Berland Y
    Am J Kidney Dis; 2008 Oct; 52(4):699-705. PubMed ID: 18585835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of cyclosporine A in the treatment of idiopathic membranous nephropathy in an Asian population.
    Lin S; Li HY; Zhou T; Lin W
    Drug Des Devel Ther; 2019; 13():2305-2330. PubMed ID: 31371924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporine treatment in idiopathic membranous nephropathy nephrotic syndrome in adults: a retrospective study spanning 15 years.
    Tao JL; Liu LL; Wen YB; Gao RT; Li H; Li MX; Li XM; Li XW
    Chin Med J (Engl); 2011 Nov; 124(21):3490-4. PubMed ID: 22340164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of infection with different immunosuppressive drugs combined with glucocorticoids for the treatment of idiopathic membranous nephropathy: A pairwise and network meta-analysis.
    Liu D; Yang Y; Kuang F; Qing S; Hu B; Yu X
    Int Immunopharmacol; 2019 May; 70():354-361. PubMed ID: 30852290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.
    Schieppati A; Perna A; Zamora J; Giuliano GA; Braun N; Remuzzi G
    Cochrane Database Syst Rev; 2004 Oct; (4):CD004293. PubMed ID: 15495098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose cyclosporine treatment in Chinese nephrotic patients with idiopathic membranous nephropathy: An uncontrolled study with prospective follow-up.
    Li J; Zhang YM; Qu Z; Zhao MH; Liu G
    Am J Med Sci; 2010 Jun; 339(6):532-6. PubMed ID: 20442650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporine versus azathioprine therapy in high-risk idiopathic membranous nephropathy patients: A 3-year prospective study.
    Naumovic R; Jovanovic D; Pavlovic S; Stosovic M; Marinkovic J; Basta-Jovanovic G
    Biomed Pharmacother; 2011 Mar; 65(2):105-10. PubMed ID: 21109389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.